TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novartis Sverige AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
178,091
|
156,689
|
161,031 |
Financial expenses |
1,091
|
821
|
620 |
Earnings before taxes |
5,117
|
5,551
|
6,417 |
EBITDA |
6,364
|
6,613
|
7,300 |
Total assets |
66,911
|
62,828
|
58,749 |
Current assets |
65,661
|
61,485
|
57,085 |
Current liabilities |
30,745
|
29,127
|
28,432 |
Equity capital |
11,885
|
8,995
|
11,181 |
- share capital |
451
|
449
|
489 |
Employees (average) |
189
|
206
|
216 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
17.8%
|
14.3%
|
19.0% |
Turnover per employee |
942
|
761
|
746 |
Profit as a percentage of turnover |
2.9%
|
3.5%
|
4.0% |
Return on assets (ROA) |
9.3%
|
10.1%
|
12.0% |
Current ratio |
213.6%
|
211.1%
|
200.8% |
Return on equity (ROE) |
43.1%
|
61.7%
|
57.4% |
Change turnover |
20,946
|
8,702
|
-582 |
Change turnover % |
13%
|
6%
|
0% |
Chg. No. of employees |
-17
|
-10
|
-12 |
Chg. No. of employees % |
-8%
|
-5%
![]() |
-5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.